Pleural Fluid Analysis
1. Indications for Thoracentesis
Pleural fluid analysis is performed whenever a patient has a pleural effusion of unclear cause on imaging, to determine whether it is a transudate or exudate and to identify the underlying etiology (infection, malignancy, heart failure, etc.) - Murray & Nadel's Textbook of Respiratory Medicine.
2. Gross/Physical Examination
- Color/turbidity: clear/straw-colored (transudate), turbid (infection), bloody, milky (chylothorax), or "anchovy paste" (amebic).
- Odor: putrid smell suggests anaerobic empyema; urine-like odor suggests urinothorax.
- Pleural fluid hematocrit: if >50% of peripheral blood hematocrit -> hemothorax (consider chest tube); 1-50% suggests malignancy, PE, or trauma; <1% is not clinically significant - Murray & Nadel's Textbook of Respiratory Medicine, Roberts and Hedges' Clinical Procedures in Emergency Medicine.
- Turbidity that clears on centrifugation is due to cells/debris; persistent turbidity suggests chylothorax or pseudochylothorax (check triglycerides, cholesterol crystals).
3. Light's Criteria - Transudate vs Exudate
This is the cornerstone of pleural fluid analysis (Fishman's Pulmonary Diseases; Henry's Clinical Diagnosis and Management by Laboratory Methods). Fluid is an exudate if ANY ONE of the following is met:
- Pleural fluid protein / serum protein ratio > 0.5
- Pleural fluid LDH / serum LDH ratio > 0.6
- Pleural fluid LDH > two-thirds the upper limit of normal serum LDH
If none are met, the fluid is a transudate. Light's criteria have high sensitivity but lower specificity, misclassifying up to ~25% of true transudates as exudates (Roberts and Hedges' Clinical Procedures in Emergency Medicine). When CHF/cirrhosis is suspected but criteria are borderline exudative, additional tests help reclassify:
- Serum minus pleural fluid protein gradient > 3.1 g/dL suggests a true transudate.
- Pleural fluid or serum NT-proBNP > 1500 pg/mL supports heart failure as the cause - Murray & Nadel's Textbook of Respiratory Medicine.
Causes:
- Transudate: CHF, cirrhosis/hepatic hydrothorax, nephrotic syndrome, hypoalbuminemia (fluid overload/hydrostatic-oncotic imbalance without pleural pathology).
- Exudate: pneumonia/parapneumonic effusion, malignancy, pulmonary embolism, tuberculosis, connective tissue disease, pancreatitis (increased capillary permeability/local pleural disease).
4. Biochemical Tests
- Glucose: low (<60 mg/dL) in empyema, malignancy, TB, rheumatoid pleuritis (rheumatoid effusion can be markedly low, <30 mg/dL).
- pH: low pH (<7.2) indicates complicated parapneumonic effusion/empyema requiring drainage, also seen in malignancy, TB, rheumatoid, esophageal rupture.
- Amylase: elevated in pancreatitis, esophageal rupture, malignancy.
- Triglycerides: >110 mg/dL confirms chylothorax; cholesterol crystals suggest pseudochylothorax.
- ADA (adenosine deaminase): elevated (>40 U/L) supports tuberculous pleuritis, especially useful in TB-endemic settings.
- NT-proBNP: elevated in cardiac-related effusions.
5. Cellular Analysis
- Total and differential WBC count:
- Neutrophil predominance -> acute process (parapneumonic effusion, PE, pancreatitis).
- Lymphocyte predominance (>50%) -> TB, malignancy, chronic process (e.g., post-CABG, lymphoma).
- Eosinophilia (>10%) -> pneumothorax, hemothorax, drug reaction, benign asbestos effusion.
- Cytology: essential to detect malignant cells (adenocarcinoma is the most common malignancy causing effusion) - Murray & Nadel's Textbook of Respiratory Medicine.
- Gram stain and culture: for suspected infection/empyema.
- AFB stain/culture, TB PCR: if tuberculosis suspected.
6. Microbiological and Immunological Studies
- Bacterial cultures (aerobic and anaerobic) for empyema.
- ANA and rheumatoid factor if autoimmune etiology suspected.
- Cytology plus flow cytometry/immunohistochemistry if lymphoma suspected.
7. Summary Table (typical exam layout)
| Parameter | Transudate | Exudate |
|---|
| Protein ratio (pleural/serum) | <0.5 | >0.5 |
| LDH ratio (pleural/serum) | <0.6 | >0.6 |
| Appearance | Clear | Cloudy/turbid/bloody |
| Cell count | Low | High |
| Common causes | CHF, cirrhosis, nephrotic syndrome | Infection, malignancy, PE, TB |
8. Clinical Correlation
The stepwise approach (gross appearance -> Light's criteria -> targeted biochemical/cellular/microbiologic tests) allows narrowing the differential efficiently without ordering every test on every sample, since routine "shotgun" testing is not cost-effective - Murray & Nadel's Textbook of Respiratory Medicine, p. (block 25, line ~1784).
Sources: Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume; Henry's Clinical Diagnosis and Management by Laboratory Methods; Fishman's Pulmonary Diseases and Disorders; Roberts and Hedges' Clinical Procedures in Emergency Medicine; The Washington Manual of Medical Therapeutics.